PYXS down 22.7% on Sep 9 2026 with no filing that explains it
PYXS-22.7%on Wed Sep 9 2026
Pyxis Oncology, Inc. Common Stock was down 22.7% on the day at $3.01, ranked #21 on 28.5× its usual five-minute volume, when TapeRank recorded this unexplained move at 07:23 ET during the pre-market session.
WHAT THE ROW LOOKED LIKE
* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
AI VERDICT
Pyxis Oncology is down 22.4% pre-market on a routine 8-K confirming the interim CEO's appointment to permanent CEO, a leadership continuity update with no new clinical, financial, or strategic disclosure. This kind of announcement does not carry the weight to explain a move of this size, leaving order flow as the more plausible driver.
FILINGS · 24H BEFORE THE MOVE
No SEC filings in the 24 hours before this was recorded. A move on an unfiled press release shows nothing here, which is what UNEXPLAINED means.
SESSION LEVELS AT CAPTURE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO